Mdm2 is the major inhibitor of the p53 tumor suppressor. Loss of Mdm2 in mice or in specific tissues of the mouse always yields p53-dependent lethal phenotypes. However, the role of Mdm2 in tissues with high turnover capacity is unknown. We have engineered mice lacking Mdm2 in the intestinal epithelium using the Cre/LoxP system. Loss of Mdm2 (Mdm2 intD ) results in viable animals, but neonates display multiple intestinal abnormalities such as hyperplasia, enterocyte vacuolization, and inflammation. These defects correlate with a drastic increase in p53-dependent apoptosis in highly proliferative and differentiated cells. Unexpectedly, the observed phenotypes disappear with age. The tissue selects against Mdm2-null cells and increases its proliferative capacity. Additionally, the intestinal stem and progenitor cell populations are enriched leading to an increase in crypt fission events. Enhanced proliferation is achieved by activation of the canonical Wnt and EGFR-mediated Ras/MAPK pathways. While Mdm2 is a critical inhibitor of p53 in the intestinal epithelium, the tissue employs a series of processes that compensate for cell death.
The proliferative capacity of cancer cells is the result of accumulation of many genetic changes. A key alteration is mutation of the p53 tumor suppressor, which acts as a transcription factor to activate genes involved in apoptosis, cell-cycle arrest, and senescence. 1 Disruption of p53 activity, as occurs in human tumors, therefore promotes cell proliferation and increased tumorigenesis.
The strong antiproliferative activity of p53 not only prevents outgrowth of malignant cells, but also has detrimental effects in normal cells when activated inappropriately. Numerous p53-negative regulators have been discovered that dampen p53 activity in normal cells. 2 Among these, Mdm2 plays a central role in restricting p53 function.
Many tumors with high Mdm2 levels retain wild-type p53. [3] [4] [5] [6] Mdm2 is an E3 ubiquitin ligase that targets p53 for proteasome-dependent degradation. [7] [8] [9] [10] In mice, loss of Mdm2 results in embryo lethality. [11] [12] [13] p53 deletion completely rescues this phenotype and demonstrates that Mdm2 is a critical inhibitor of p53 in vivo. Studies to elucidate tissuespecific functions of Mdm2 show that mice that express about 30% of the total Mdm2 protein levels display a decreased body weight, show defects in hematopoiesis, and are more radiosensitive than control animals due to increased p53-mediated apoptosis.
14 Loss of Mdm2 in cells of the central nervous system or cardiomyocytes results in embryonic lethality due to p53-dependent apoptosis. [15] [16] [17] Also, deletion of Mdm2 specifically in smooth muscle cells or in osteoblasts show p53-mediated lethality. 18, 19 These studies confirm that Mdm2 is a potent inhibitor of p53 in a variety of specialized cells. Although the function of Mdm2 has been elucidated in the aforementioned cell types, it remains unknown how Mdm2 modulates p53 activity in tissues with high cellular turnover. We, therefore, examined the role of Mdm2 in the intestinal epithelium as it is composed of both highly proliferative and terminally differentiated cells.
The murine intestinal epithelium differentiates into a singlelayered epithelium around 14.5 days of gestation. 20 Soon after, this layer invaginates to form intervillus pockets that contain stem and progenitor cells. Terminally differentiated cells become restricted to finger-like protrusions known as villi. Around postnatal day 7 (P7), rudimentary crypts of Lieberkü hn start to emerge from the intervillus pockets and become the proliferative region. 21 Cells in the crypt region migrate upward toward the villus compartment and become terminally differentiated. Finally, 2-7 days after leaving the crypts, mature epithelial cells are sloughed into the intestinal lumen. 22 Thus, the intestinal epithelium represents the tissue with the fastest cellular turnover.
p53 plays an important role in the homeostasis of the intestinal epithelium during DNA damage. Undifferentiated cells at the base of the crypts undergo p53-dependent apoptosis in response to ionizing radiation, [23] [24] [25] while more differentiated cells undergo cell-cycle arrest. 25 Thus, undifferentiated epithelial cells appear more sensitive to p53-mediated apoptosis, while differentiating epithelial cells are prone to p53-dependent cell-cycle arrest in response to DNA damage. To understand the in vivo significance of Mdm2 in regulating p53 activity in highly proliferative tissues, we implemented the Cre-LoxP strategy to delete Mdm2 in the intestinal epithelium. We found that Mdm2 loss leads to apoptosis in all compartments of the epithelium. With time, however, the tissue implements a variety of mechanisms to compensate for cell loss.
Results
Mice survive Mdm2 loss in the intestinal epithelium but display severe intestinal abnormalities. Loss of Mdm2 in mice causes embryo lethality. [11] [12] [13] Therefore, conditional deletion of Mdm2 is required to assess the role of Mdm2 in more specialized cells. A loxP-flanked Mdm2 allele (Mdm2 FM ) generated in our laboratory phenocopies the original Mdm2-null allele upon Cre recombination. 12, 26 To address the in vivo role of Mdm2 in regulating p53 activity in tissues with high turnover capacity, we generated mice lacking Mdm2 exclusively in the intestinal epithelium using the Villin Cre (VilCre) transgene. 27 We verified the specificity and efficiency of VilCre in targeting intestinal epithelial cells by mating mice carrying this transgene to the ROSA26R reporter, 28 and performing b-galactosidase assays. Strong and specific b-galacotsidase activity was detected in almost all intestinal epithelial cells at embryonic day 14.5 (E14.5) and at 8 weeks (Supplementary Figure 1) .
To Table 1 ). We observed the recombination in cells from small intestines and colons, but not in tails, of Mdm2 intD mice at 3 days of age ( Figure 1a ). The nonrecombined alleles detected are derived from either nonrecombined epithelium or other cell types present in the sample.
Characterization of Mdm2 intD mice showed that by postnatal day 3 (P3), these mice displayed a significant reduction in body weight relative to control littermates (Figure 1b ; control, 2.3 g ± 0.035; Mdm2 intD , 1.67 g ± 0.059; t-test; Po0.001; nX23 per group). The presence of milk in the stomachs of small Mdm2 intD mice suggests that the loss of body weight was not due to an inability to obtain milk (data not shown). Sections through the intestinal tract at P3 revealed that Mdm2 intD pups exhibited abnormal morphology in intervillus pockets as well as in villi (Figure 1c and d) . Notably, smaller Mdm2 intD pups showed a more severe phenotype than Mdm2 intD pups of normal size and weight. The intervillus pockets of P3 Mdm2 intD mice displayed hypertrophy, hyperplasia, disorganization, and loss of polarity. Additionally, these pockets were significantly wider in mutant pups relative to controls (Figure 1e and f; control, 1±0.08; Mdm2 intD , 1.79±0.22; t-test, P ¼ 0.004). On the other hand, the villus region of P3 Mdm2 intD pups showed atrophy and frequently displayed abnormal structures that appear to be vacuoles (Figure 1g ). P3 Mdm2 intD pups occasionally showed edema and neutrophil infiltration into the mucosa, indicative of inflammation ( Figure 1d , and data not shown). Morphological analysis during embryogenesis revealed the absence of vacuoles in Mdm2 intD intestines (Supplementary Figure 2) , suggesting that the vacuoles observed at P3 are caused by inflammation. Staining using differentiation-specific markers to distinguish enterocyte, goblet, and enteroendocrine cells (Paneth cells are absent at this developmental stage) revealed the presence of all cell types in Mdm2 intD intestine ( Supplementary Figure 3a-d) . Villin, alkaline phosphatase, alcian blue, and synaptophysin staining was similar in intestines of P3 Mdm2 intD pups and controls (Supplementary Figure 3) . The aforementioned phenotypes were never observed in mice that carried one wild-type Mdm2 allele with or without VilCre þ .
Mdm2-modulated p53 activity in highly proliferative and terminally differentiated cells of the intestinal epithelium. As Mdm2 is an E3-ubiquitin ligase that targets p53 for proteosome-mediated degradation, [7] [8] [9] [10] we tested whether the loss of Mdm2 in cells results in p53 stabilization. [15] [16] [17] [18] As predicted, P3 Mdm2 intD pups displayed high levels of p53 protein in intestinal epithelial cells, while control pups lacked p53 expression (Figure 2a ). High p53 levels were observed in highly proliferative cells of the intervillus pockets and in terminally differentiated cells in the villus region (Figure 2a ). In general, smaller mice showed more p53-positive cells. These data reaffirm the absence of Mdm2 in the intestinal epithelium of Mdm2 intD neonates. Loss of Mdm2 in the mouse induces p53-mediated apoptosis at E3.5. [11] [12] [13] We, therefore, examined the intestines of small (p1.5 g) P3 Mdm2
intD pups for apoptosis. Loss of Mdm2 triggered a large increase in the number of apoptotic cells in the intervillus region (Figure 2b and c; control, 0.045 ± 0.03; Mdm2 intD , 2.50 ± 0.20; t-test, P ¼ 0.002). A significant number of apoptotic cells were also present in intestinal villi of P3 Mdm2 intD mice (Figure 2b ; control, 0.06 ± 0.08; Mdm2 intD , 0.90 ± 0.01; t-test, P ¼ 0.005). Finally, P3 Mdm2 intD pups displayed numerous apoptotic cells in the large intestine, emphasizing the importance of Mdm2 in this region as well (data not shown). Quantitative RNA analysis indicated that the apoptotic p53-target genes PUMA and BAX, but not PERP and NOXA, were significantly upregulated in Mdm2 intD pups compared to controls (Figure 2d ; t-test, Po0.02, n ¼ 3-5 per group). Although cell-cycle arrest was not observed in Mdm2 intD mice (see below), the p53-target genes, p21 and cyclin G1, were also upregulated in mutant intestines ( Figure 2d and Supplementary Figure 4) . Lastly, the increase in apoptosis and morphological defects observed in Mdm2 intD pups were completely rescued upon deletion of p53 (Figure 2c and e). Collectively, these data indicate that Mdm2 is a major regulator of p53 stability and activity in both proliferative and terminally differentiated cells of the intestinal epithelium.
Intestinal epithelium compensated for cellular loss in the absence of Mdm2. To further explore the mechanisms by which Mdm2 intD mice survive, we examined the phenotypes of adult mice. Adult Mdm2 intD mice showed a normal intestinal morphology (Figure 3a ). Adult Mdm2 intD intestines showed only a few p53-positive cells in all regions of the small intestine and colon in contrast to the intestines of P3 Mdm2 intD pups (compare Figure 2a versus Figure 3b ). Moreover, adult Mdm2 intD mice showed a drastic reduction in the number of apoptotic cells in intestines relative to P3 Mdm2 intD pups (Figure 3c ; Mdm2 intD at P3, 2.50 ± 0.20; Mdm2 intD at 8 weeks (jejunum), 0.595±0.035; t-test, P ¼ 0.007). This phenomenon was observed in the duodenum, jejunum, and ileum, and in the colon of adult mutant animals (data not shown). Lastly, P3 Mdm2 intD pups with reduced body weight, gained weight as they aged. At 8 weeks of age, the body weight of these mutants showed no significant difference as compared to controls (Figure 3d and data not shown). These data demonstrate that the intestinal epithelium is able to compensate for cell loss due to p53 activity.
The intestinal epithelium selected against cells with high p53 activity. A possible mechanism for compensation is that some intestinal cells in adult Mdm2 intD mice retain Mdm2. To test this possibility, Mdm2 intD mice carrying the ROSA26R reporter were first analyzed for recombination at the ROSA26R locus. LacZ-stained sections showed uniform expression of VilCre throughout the epithelium in R26R/ þ VilCre þ P3 pups, indicating high efficiency of recombination (Figure 4a ). In contrast, a chimeric pattern was observed in intestinal epithelial cells of P3 Fold increase in intervillus width P = 0.004 pups. Eight-week-old Mdm2 intD mice showed a further decrease in recombination events in the intestinal epithelium; few patches were observed in the crypt compartment suggesting that most crypts have already lost the Cre recombinase (Figure 4a ).
To investigate whether the loss of recombination also occurred at the Mdm2 locus with age, we analyzed the recombination using primer sets that distinguish the wild-type, Mdm2 conditional (FM), and recombined (intD) alleles (Figure 1a) , and DNA isolated from scraped intestinal mucosa of 8-week-old animals to enrich for an epithelial population.
Control 8-week-old Mdm2
FM/-VilCreÀ mice did not have the recombined allele, while Mdm2 FM/ þ VilCre þ mice recombined the Mdm2 conditional allele with high efficiency (Figure 4b ). In 8-week-old Mdm2 FM/-VilCre þ mutants, the number of recombined cells was greatly reduced as compared to 8-week-old Mdm2 FM/ þ VilCre þ mice. As the 3-day-old Mdm2 FM/-VilCre þ pups also show high efficiency of recombination events (Figure 4b ), loss of recombination at the Mdm2 locus occurs with time. Together, these data suggest that the intestinal epithelium selects against cells that have high p53 activity.
A potential mechanism by which the intestinal epithelium selects against cells with high p53 activity is by loss of the VilCre transgene. To investigate this possibility, real-time PCR was performed using DNA from scraped intestinal VilCre þ mice. The 8-week-old Mdm2 FM/-VilCre þ mutants showed greater than 100-fold reduction in the total amount of the VilCre transgene in the small intestine relative to tail (Table 1 ). These data suggest that the intestinal epithelial cells from Mdm2 intD mice spontaneously delete the VilCre transgene and thus are able to expand.
Multiple mechanisms compensated for p53 activation in the intestinal epithelium. To further elucidate the mechanisms of cellular compensation upon p53 activation, we investigated the proliferation capacity of the intestinal epithelium in Mdm2 intD mice. P3 Mdm2 intD mice showed a twofold increase in Ki-67-positive cells per intervillus unit as compared to control animals, indicating that intestines of these mutants have an accelerated proliferative capacity (Figure 5a ; control, 10.43 ± 0.189; Mdm2 intD , 18.98 ± 2.85; t-test, P ¼ 0.007). Moreover, BrdU assays performed in adult intestines showed that Mdm2 intD mice retained an increased capacity to proliferate relative to age-matched control animals (Supplementary Figure 5; control, 26.2 ± 0.22; Mdm2 intD , 36.9±2.6; t-test, P ¼ 0.036). However, the proliferation index of the intestine was relatively less in adult mutants than in P3 mutants. Therefore, the intestinal epithelium compensates for p53 activation by increasing cell proliferation.
The postnatal growth of the small intestine occurs through two major processes: crypt hyperplasia and crypt fission. 29 Given that neonatal Mdm2 intD mice recovered from the detrimental effects of p53 activation, we counted the number of crypt fissions. Indeed, P3 Mdm2 intD pups showed a drastic increase in the frequency of crypt fissions in the small intestine (Figure 5b ; control, 1.225 ± 0.64; Mdm2 intD , 4.972 ± 1.28; t-test, P ¼ 0.0001). Thus, another mechanism by which Mdm2 intD mice survive is the ability to increase crypt fission events.
The crypt fission process is thought to depend on the multiplication of intestinal stem cells. 30 We, therefore, performed immunohistochemistry using the intestinal stem and progenitor cell marker, Musashi-1 (Msi-1). 31, 32 Analysis of expression of Msi-1 in P3 Mdm2 intD mice revealed more Msi-1-positive cells in the small intestine of Mdm2 intD pups than in control littermates (Figure 5c ; control, 5.647 ± 0.472; Mdm2 intD , 9.338±0.614; t-test, Po0.001). These results suggest that the intestinal stem and progenitor cell populations are increased in Mdm2 intD neonates.
The canonical Wnt and EGFR-mediated Ras/MAPK signaling pathways were induced in the intestines of Mdm2 intD mice. The canonical Wnt pathway plays an important role in maintaining the proliferation capacity and stem-cell population of the intestinal epithelium. 33 The Small intestines of P3 Mdm2 intD pups displayed drastic accumulation of this membrane glycoprotein in intervillus pockets as compared to controls (Figure 6b ). Together, these data imply that the b-catenin/TCF-4 complex is active in the intestinal epithelium of P3 Mdm2 intD pups. To investigate other pathways that may be involved in tissue compensation in the absence of Mdm2, we performed gene expression profiles of RNA isolated from whole small PCR-based recombination analysis in 3-day and 8-week-old mouse tissues (nX3 per group) using primers A, B, and C (see Figure 1a) . Asterisk marks the band amplified using primers A and B, which represents the wild-type or Mdm2-null alleles. SI, small intestine; T, tail intestines of small Mdm2 intD pups by genome-wide microarray analyses. We identified 219 genes that showed at least a twofold change and exhibited a P-value of less than 0.05 and were either upregulated (139 genes) or downregulated (80 genes) in the intestine of Mdm2 intD neonates as compared to control mice (Supplementary Table 2 ). Many of these genes are involved in immune response, xenobiotic and lipid metabolism, and cellular trafficking, suggesting that these processes are altered in the intestine of Mdm2 intD mutants. The fact that these mutants show the loss of body weight supports this hypothesis. Notably, several well-known p53-target genes were upregulated in the intestine of Mdm2 intD neonates, confirming that these mutants display high p53 activity (Supplementary Table 2 ). The activation of some of these genes (i.e., p21, cyclin G1) was validated in these mutants (Figure 2d ). Lastly, we detected a cluster of upregulated genes in the mutant intestines that have important functions in signal transduction such as amphiregulin, epiregulin, calcyclin, and augmenter of liver regeneration (ALR; Supplementary Table 2 ). Amphiregulin and Epiregulin are members of the epidermal growth factor family (known as EGF-like factors) that bind to EGF receptors (EGFR) and initiate a signal transduction cascade that activates pathways such as the Ras-activated, mitogenactivated protein kinase (MAPK) pathway (Figure 6c ). 35 Therefore, we postulated that the EGFR-mediated Ras/ MAPK pathway might play an important role during the tissue regeneration in response to p53 activation. To test this hypothesis, we first performed reverse transcription real-time PCR to analyze the mRNA expression of amphiregulin and epiregulin in P3 Mdm2 intD pups. We detected significantly higher mRNA levels of both amphiregulin and epiregulin in the intestines of Mdm2 intD pups than in the intestines of control mice (Figure 6d ; amphiregulin, control ¼ 1.107 ± 0.3095, Mdm2 intD ¼ 3.906±0.8370 (P ¼ 0.0095, nX4 per group); epiregulin, control ¼ 1.009 ± 0.09861, Mdm2 intD ¼ 5.716 ± 0.9555 (P ¼ 0.008, nX3 per group)). Immunohistochemistry revealed that the intestines of P3 Mdm2 intD pups show increased levels of EGFR along the entire intervillus-villus axis, whereas control animals did not stain for EGFR (Figure 6e) . Moreover, intestines of P3 Mdm2 intD pups showed a dramatic increase in the expression of phosphorylated-ERK1/2 in the intervillus region as compared to controls (Figure 6f) . Collectively, these data indicate that, like the canonical Wnt pathway, the EGFR-mediated Ras/MAPK pathway is active in the intestinal epithelium of P3 Mdm2 intD pups. Note that the pictures of both control and mutant intestines were taken at the same magnification, but the mutant intestines are larger due to the hyperplastic and hyperthrophic phenotype observed in these mutants
Discussion
The data demonstrate that Mdm2 is a critical inhibitor of p53 activity in the intestinal epithelium. Absence of Mdm2 in this tissue results in an accumulation of p53 protein and enhanced p53-mediated apoptosis in both highly proliferative and terminally differentiated cells. Thus, p53 activation results in severe intestinal abnormalities early in life. The presence of apoptotic cells in differentiated intestinal epithelia with loss of Mdm2 was unexpected as earlier studies revealed that p53-mediated apoptosis is a rare event in this cell type under normal conditions or upon DNA damage. 36 Therefore, these early studies show that sufficient Mdm2 levels in terminally differentiated intestinal epithelial cells keep p53 activity at bay in wild-type mice. The inhibition of p53 activity by Mdm2 also occurs in differentiated smooth muscle and brain cells. 16, 18 These data suggest that Mdm2 dampens p53 activity in differentiated cells despite the fact that they will never divide.
Other studies also indicate that the partial loss of Mdm2 increases apoptosis in the gut, 37 but failed to note the other defects seen in our mice probably due to the presence of some Mdm2. Our Mdm2 intD mice also exhibit inflammation, presence of vacuoles, and increase in intervillus width. Most importantly, increased apoptosis was observed in both, highly proliferative and terminally differentiated intestinal epithelial cells, a phenotype not observed in mice retaining some Mdm2. In mice expressing a tamoxifen inducible p53 allele, intestinal defects were also noted, although not characterized in detail. 38 Although Mdm2 mutants exhibit numerous intestinal defects early in life, such defects disappear with age and these mice have a normal lifespan. The intestinal epithelium compensates for the detrimental effects of p53 activation through multiple mechanisms. First, intestines lacking Mdm2 are able to select against cells that are undergoing recombination through the loss of VilCre. A similar phenomenon was reported in mice with the deletion of c-Myc in intestinal crypts. 39 Second, the tissue increases proliferation in young Mdm2 intD mice to balance cell loss due to p53-dependent apoptosis. Third, the intestinal epithelium increases the number of crypt fission events upon Mdm2 deletion, which promotes intestinal growth. 40 Fourth, the intestinal epithelium also compensates for p53 activation by increasing the putative stem-cell population. Thus, the increase in proliferation and crypt fission events is likely the result of an expanded stem-cell population. Thus, multiple mechanisms are coordinated to compensate for cell loss due to p53 activation.
Finally, the tissue senses the cellular abnormalities in the intestine and triggers the activation of the canonical Wnt, and EGFR-Ras/MAPK pathways, thus, promoting survival. The canonical Wnt/b-catenin pathway is linked to intestinal stemcell maintenance and epithelial homeostasis. For example, loss of the b-catenin partner, TCF-4, in mice results in lethality due to complete absence of the proliferative compartment of the intestinal epithelium. 41 On the other hand, the role of the EGFR-mediated Ras/MAPK pathway in intestinal regeneration is novel. In addition to their role in tissue homeostasis, these two pathways contribute to tumorigenesis. 33, 42 Thus, normal and neoplastic cells share similar molecular pathways that allow cell proliferation. However, normal cells cease to proliferate when the tissue reaches homeostasis, whereas tumor cells continue proliferating indefinitely. Despite the activation of the Wnt/b-catenin and EGFR-mediated Ras/ MAPK pathways, Mdm2 intD mice do not develop tumors. It would be of great interest to elucidate the molecular mechanisms normal cells employ to halt proliferation when the tissue reaches homeostasis.
Materials and Methods
Mice. All animal protocols were approved by the Institutional Animal Care and Use Committee. All mice were 490% C57BL/6. VilCre mice were crossed with Mdm2 FM conditional mice. 27, 26 Recombination was assayed by PCR using primers described previously. 26 Intestines of P3 pups were washed in cold phosphate buffered saline (PBS), rolled, incubated in 10% formalin for up to 48 h, and embedded in paraffin. Intestines of 8-week-old mice were cut into sections (duodenum, jejunum, ileum, and colon), and luminal contents flushed with cold PBS before rolling.
b-galactosidase activity assays. b-galactosidase activity in embryos was performed as described. 15 Postnatal samples were fixed in 4% paraformaldehyde at 41C for 1 h. Samples were cryoprotected in a sucrose gradient (10% sucrose/HBSS overnight; 15% sucrose/HBSS for 6 h, and 20% sucrose/HBSS for 6 h) at 4 1C, embedded in optimum cutting temperature compound (Sakura), and 10 mm sections cut at À201C. Sections were fixed in 0.2% glutaraldehyde for 2 min, washed in PBS (pH 8.3), and stained (1 mg/ml X-Gal, 50 mM K 3 Fe(CN) 6 , 50 mM K 4 Fe(CN) 6 .3H 2 O, 2% NP-40, 1% sodium desoxycholate, 1 M MgCl 2 in PBS (pH 8.3)) overnight at 371C.
Immunohistochemistry and immunofluorescence. The antibodies used for immunohistochemistry and immunofluorescence studies are listed in Supplementary Table 3 . Immunohistochemistry was performed as described. 3 For immunofluorescence, epitope retrieval was performed by steaming samples in 10 mM citric acid (pH 6.0) for 30 min. Samples were incubated in blocking serum (10% goat serum in PBS-0.1% Tween-20) for 1 h at room temperature, then with primary antibodies, followed by rinsing in PBS, and incubation with the fluorochrome-conjugated secondary antibody.
Microarray and reverse transcriptase real-time analyses. RNA was isolated from whole small intestines of P3 mice (RNAeasy kit, Qiagen). Five mice per group were analyzed individually using the Affymetrix GeneChip Mouse Genome 430 2.0 Array. Student's t-test was used on log-base transformed data. Samples were considered statistically significant if P-values were less than 0.05 and showed at least twofold of change. For validation, RNA was reverse transcribed using the First-Strand cDNA Synthesis kit from Amersham Biosciences. Real-time was performed using the primer sets listed in Supplementary Table 4 . Relative DNA levels were normalized to the value of GAPDH for each reaction.
